Vitamin D receptor gene polymorphism and hepatocellular carcinoma in chronic hepatitis C patients

Background Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide. Vitamin D receptor (VDR) gene polymorphisms were linked to different cancers. This study was carried out to assess the possible relation between VDR gene polymorphism and the occurrence of HCC in chronic hepatitis C patie...

Full description

Saved in:
Bibliographic Details
Published in:Egyptian Liver Journal 2020-11, Vol.10 (1), p.55-7
Main Authors: Mosaad, Hala, Emam, Emad A, Hamed, Emad F, El Demerdash, Ezzat A, Hussein, Samia
Format: Article
Language:English
Subjects:
Alfacalcidol
Body mass index
Calcifediol
Cancer
Carcinoma
Chronic hepatitis C
Creatinine
Enzymes
Genes
Genetic aspects
Genetic polymorphisms
Genotype & phenotype
Hemoglobin
Hepatitis C
Hepatocellular carcinoma
Infections
Liver cancer
Medical research
Medicine, Experimental
Molecular biology
Polymerase chain reaction
Polymorphism
Variance analysis
Vitamin D
Vitamin D receptor gene polymorphism
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide. Vitamin D receptor (VDR) gene polymorphisms were linked to different cancers. This study was carried out to assess the possible relation between VDR gene polymorphism and the occurrence of HCC in chronic hepatitis C patients. This study included 102 subjects classified into three groups. Group A included 34 healthy subjects as control. Group B included 34 chronic hepatitis C patients with HCC. Group C included 34 chronic hepatitis C patients without HCC. Estimation of Apa-1 VDR gene polymorphism was performed by restriction fragment length polymorphism-Polymerase chain reaction (RFLP-PCR). Results In HCC group, C allele was more frequent than A allele (80.88% and 19.12%), respectively. In chronic hepatitis group, C allele was more frequent than A allele (64.71% and 35.29%), respectively. In control group, A allele was more frequent than C allele (73.53% and 26.47%), respectively. Genotype CC + CA was dominant in HCC group (91.18%) and chronic hepatitis group (79.41%). In the control group, the dominant genotype was AA (58.82%). Moreover, there was a significant relation between Apa-1 VDR genotype CC and tumor size. Conclusions There is an association between VDR Apa-1 polymorphism and the occurrence of HCC in chronic hepatitis C patients.
ISSN:2090-6218
2090-6226
DOI:10.1186/s43066-020-00063-7